Referencias bibliográficas

  1. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014; 4: 97-104.
  2. Mayrink, J., Costa, M. L., Cecatti, J. G., & Preeclampsia: What the Obstetrician Needs to Know (2020). Preeclampsia: What the Obstetrician Needs to Know. Current Hypertension Reports, 22(1), 1–10.
  3. Chaiworapongsa, T., Romero, R., Kim, Y. M., Kim, G. J., Kim, M. R., Espinoza, J., Bujold, E., Gonçalves, L. F., & Gomez, R. (2008). Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. Journal of Maternal-Fetal and Neonatal Medicine, 21(2), 89–94.
  4. Phipps, E., Prasanna, D., Brima, W., & Jim, B. (2019). Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clinical Journal of the American Society of Nephrology, 11(6), 1102–1113.
  5. Brosens, I., Pijnenborg, R., & Vercruysse, L. (2019). The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology, 204(3), 193–201.
  6. Matsubara, K., Matsubara, Y., Hyodo, S., & Katayama, T. (2019). IGF-1 in the brain, liver, and serum of pre-eclampsia patients and their potential in the prediction of fetal growth restriction and placental weight. Prenatal Diagnosis, 21(6), 471–479.
  7. Brewster, J., Orsi, N. M., & Kingdom, J. (2018). Utero-Placental Vascularization and Placental Metabolic Reactions are Compromised in Preeclampsia. Hypertension, 21(6), 417–424.
  8. Jaakko S, Kaartokallio T, Lokki I et al. Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy. JAMA Cardiol.2023 Jul; 8(7): 674–683.
  9. Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017 Nov;50(5):589-595.
  10. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017 Jun 28.
  11. Hairong Xu, Bryna Shatenstein, Zhong-Cheng Luo, Shuqin Wei, William Fraser, Role of nutrition in the risk of preeclampsia. Nutrition Reviews, Volume 67, Issue 11, 1 November 2009, Pages 639–657.
  12. Oh C , Keats EC, Bhutta ZA. Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.Nutrients 2020, 12, 491; doi:10.3390/nu12020491
  13. Pengo, Martino F, Rossi. Obstructive sleep apnea, gestational hypertension and preeclampsia: a review of the literature. Current Opinion in Pulmonary Medicine 20(6):p 588-594, November 2014.
  14. Paulsen, C.P.; Bandak, E.; Edemann-Callesen, H.; Juhl, C.B.; Händel, M.N. The Effects of Exercise during Pregnancy on Gestational Diabetes Mellitus, Preeclampsia, and Spontaneous Abortion among Healthy Women—A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2023, 20, 6069.
  15. Yu Y, Zhang S, Mallow EB et al. The Combined Association of Psychosocial Stress and Chronic Hypertension with Preeclampsia. Am J Obstet Gynecol. 2013 November ; 209(5).
  16. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr. 2007; 27: 363-388.
  17. McNestry C, Killeen SL, Crowley RK, McAuliffe Pregnancy complications and later life women’s health. Acta Obstet Gynecol Scand, 2023 May;102(5):523-531.